The IMID Forum

The Immune-Mediated Inflammatory Disease Forum
  • 4,9 (8)
  • ОБРАЗОВАНИЕ
  • ЕЖЕДНЕВНО

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

  1. ACR Daily Highlights Day 4

    -2 ДН.

    ACR Daily Highlights Day 4

    Join Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 4 of ACR 2025 (Wednesdsy, 29th of October)

    2 мин.
  2. ACR Daily Highlights: Day 3

    -3 ДН.

    ACR Daily Highlights: Day 3

    Join Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 3 of ACR 2025 (Tuesday 28th of October)

    4 мин.
  3. Pathways Modulating IMIDs: Webinar Highlights Podcast

    -3 ДН.

    Pathways Modulating IMIDs: Webinar Highlights Podcast

    Professors Janet Pope and John Isaacs discuss all the highlights from the 'Pathways Modulating IMIDs' webinar.

    25 мин.
  4. ACR Daily Highlights: Day 2

    -4 ДН.

    ACR Daily Highlights: Day 2

    Join Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 2 of ACR 2025 (Monday, 27th of October)

    4 мин.
  5. ACR Daily Highlights: Day 1

    -5 ДН.

    ACR Daily Highlights: Day 1

    Join Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of ACR 2025 (Sunday, 26th of October)

    4 мин.
  6. ACR 2025 Preview Podcast

    22 ОКТ.

    ACR 2025 Preview Podcast

    Join Professors Peter Nash, Janet Pope and Atul Deodhar as they preview what they are most looking forward to this ACR, introducing some of the top chosen abstracts and posters in RA, AxSpA and PsA so that you can better plan your time at what will be a busy and exciting congress. #ACR2025

    23 мин.
  7. Discussing PsA: Comparative effectiveness of biologic and targeted therapies in PsA: Insights from PARWCH and KEEPsAKE studies

    9 ОКТ.

    Discussing PsA: Comparative effectiveness of biologic and targeted therapies in PsA: Insights from PARWCH and KEEPsAKE studies

    Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘the effectiveness and safety of upadacitinib with secukinumab and adalimumab’ and ‘the efficacy of long-term treatment with risankizumab across the updated GRAPPA domains and key related conditions of PsA’.

    19 мин.
  8. Author Interview: Doctor David Kellner, September 2025

    2 ОКТ.

    Author Interview: Doctor David Kellner, September 2025

    Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor David Kellner, an IGNITE-MSCR Fellow of the Division of Rheumatology, from UCLA Medical Centre, LA, USA, as they discuss his recent review ‘Effect of glucagon-like peptide 1 receptor agonists on patients with rheumatoid arthritis’.

    23 мин.
См. все (378)

Оценки и отзывы

4,9
из 5
Оценок: 8

Об этом подкасте

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

Информация

  • Автор
    The Immune-Mediated Inflammatory Disease Forum
  • Годы выхода
    2015 - 2025
  • Выпуски
    378
  • Ограничения
    Без ненормативной лексики
  • Авторские права
    © All rights reserved
  • Сайт подкаста
    The IMID Forum

Вам может также понравиться